Evidence map›Paper›PMID 23423415›Full record

Trial reportJAMA2013

Association between telomere length and experimentally induced upper respiratory viral infection in healthy adults.

Sheldon Cohen, Denise Janicki-Deverts, Ronald B Turner, Margaretha L Casselbrant, Ha-Sheng Li-Korotky, Elissa S Epel, William J Doyle

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in JAMA, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 4 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 4 syntheses or guidelines pooled it, 147 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis.American journal of respiratory and critical care medicine · 2019
    Trial
  7. Trial
  8. Article
  9. Effect of SARS-CoV-2 infection on sperm telomere length.Journal of assisted reproduction and genetics · 2025
    Article
  10. Reflections on resilience.Development and psychopathology · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Biomarkers of aging.Science China. Life sciences · 2023
    Review
  19. Zebrafish models of COVID-19.FEMS microbiology reviews · 2023
    Review
  20. Association between leukocyte telomere length and COVID-19 severity.The Egyptian journal of medical human genetics · 2023
    Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sheldon CohenDepartment of Psychology, Carnegie Mellon University, 5000 Forbes Ave, Pittsburgh, PA 15213, USA. scohen@cmu.edu
Denise Janicki-Deverts
Ronald B Turner
Margaretha L Casselbrant
Ha-Sheng Li-Korotky
Elissa S Epel
William J Doyle
Carnegie Mellon University · US

Funding

UNIVERSITY OF PITTSBURGH CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE: BPCAUL1RR024153 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$73.9M
University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
An Evaluation of Treatment with Omalizumab to Improve the Asthmatic Response to aU01AI100799 · NIAID · UNIVERSITY OF VIRGINIA · PI HEYMANN, PETER W, PLATTS-MILLS, THOMAS A. · 2012 to 2015
$5.3M
Social and psychological risk for infectious illnessR01AI066367 · NIAID · CARNEGIE-MELLON UNIVERSITY · PI COHEN, SHELDON A · 2005 to 2010
$2.8M
Social Ties and Health: Aggregating Data from Five Viral-Challenge TrialsR01AT006694 · NCCIH · CARNEGIE-MELLON UNIVERSITY · PI COHEN, SHELDON A · 2011 to 2015
$1.5M
Stress, Cellular Aging and Susceptibility to Infectious DiseaseRC1AT005799 · NCCIH · CARNEGIE-MELLON UNIVERSITY · PI COHEN, SHELDON A · 2009 to 2010
$448k
NCATS NIH HHS UL1 TR000005NCATS NIH HHS UL1TR000005NCCIH NIH HHS AT006694NCCIH NIH HHS R01 AT006694NCCIH NIH HHS RC1 AT005799NCRR NIH HHS UL1 RR024153NCRR NIH HHS UL1RR024153NIAID NIH HHS AI066367NIAID NIH HHS R01 AI066367NIAID NIH HHS U01 AI100799
6 · The paper itself

Abstract

importanceAlthough leukocyte telomere length is associated with mortality and many chronic diseases thought to be manifestations of age-related functional decline, it is not known whether it relates to acute disease in younger healthy populations.

objectiveTo determine whether shorter telomeres in leukocytes, especially CD8CD28- T cells, are associated with decreased resistance to upper respiratory infection and clinical illness in young to midlife adults. DESIGN, SETTING, AND

participantsBetween 2008 and 2011, telomere length was assessed in peripheral blood mononuclear cells (PBMCs) and T-cell subsets (CD4, CD8CD28+, CD8CD28-) from 152 healthy 18- to 55-year-old residents of Pittsburgh, Pennsylvania. Participants were subsequently quarantined (single rooms), administered nasal drops containing a common cold virus (rhinovirus 39), and monitored for 5 days for development of infection and clinical illness.

main outcome measuresInfection (virus shedding or 4-fold increase in virus-specific antibody titer) and clinical illness (verified infection plus objective signs of illness).

resultsRates of infections and clinical illness were 69% (n = 105) and 22% (n = 33), respectively. Shorter telomeres were associated with greater odds of infection, independent of prechallenge virus-specific antibody, demographics, contraceptive use, season, and body mass index (PBMC: odds ratio [OR] per 1-SD decrease in telomere length, 1.71 [95% CI, 1.08-2.72]; n = 128 [shortest tertile 77% infected; middle, 66%; longest, 57%]; CD4: OR, 1.76 [95% CI, 1.15-2.70]; n = 146 [shortest tertile 80% infected; middle, 71%; longest, 54%]; CD8CD28+: OR, 1.93 [95% CI, 1.21-3.09], n = 132 [shortest tertile 84% infected; middle, 64%; longest, 58%]; CD8CD28-: OR, 2.02 [95% CI, 1.29-3.16]; n = 144 [shortest tertile 77% infected; middle, 75%; longest, 50%]). CD8CD28- was the only cell population in which shorter telomeres were associated with greater risk of clinical illness (OR, 1.69 [95% CI, 1.01-2.84]; n = 144 [shortest tertile, 26%; middle, 22%; longest, 13%]). The association between CD8CD28- telomere length and infection increased with age (CD8CD28- telomere length × age interaction, b = 0.09 [95% CI, 0.02-0.16], P = .01, n = 144). CONCLUSION AND RELEVANCE: In this preliminary study among a cohort of healthy 18- to 55-year-olds, shorter CD8CD28- T-cell telomere length was associated with increased risk for experimentally induced acute upper respiratory infection and clinical illness.

Indexed as

Telomere ShorteningAdolescentAdultAge FactorsCD28 AntigensCD8 AntigensCommon ColdDisease SusceptibilityFemaleHumansMaleMiddle AgedOdds RatioRespiratory Tract InfectionsRhinovirusRiskCD28 AntigensCD8 Antigens

Identifiers

PMID23423415
PMCPMC3786437
OpenAlexW2036623477

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.